Role of H3F3A (H3G34W) antibody in the diagnosis of giant cell tumour of bone in the paediatric age group
- 13 March 2025
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 269, 155906
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Giant cell tumor of bone in the pediatric population: a retrospective study highlighting cases of metaphyseal only location and increased local recurrence rates in skeletally immature patientsSkeletal Radiology, 2023
- Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?World Journal of Pediatrics, 2020
- Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsyCancer Cytopathology, 2018
- Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of boneHuman Pathology, 2018
- Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR)Pathology - Research and Practice, 2018
- Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimicsThe Journal of Pathology: Clinical Research, 2015
- Giant Cell Tumor of Bone: Current Treatment OptionsCurrent Treatment Options in Oncology, 2014
- Giant cell tumor of the extremity: A review of 349 cases from a single institutionCancer Treatment Reviews, 2010
- Giant Cell Tumor of BoneOrthopedic Clinics of North America, 2006
- Giant cell tumor in children and adolescentsSkeletal Radiology, 1993